TYROSINE PHOSPHORYLATION OF MB-1, B29, AND HS1 PROTEINS IN HUMAN B-CELLS FOLLOWING RECEPTOR CROSS-LINKING

被引:10
|
作者
HATA, D
NAKAMURA, T
KAWAKAMI, T
KAWAKAMI, Y
HERREN, B
MAYUMI, M
机构
[1] KYOTO UNIV,FAC MED,DEPT PEDIAT,SAKYO KU,KYOTO 606,JAPAN
[2] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 1,TOKYO 113,JAPAN
[3] LA JOLLA INST ALLERGY & IMMUNOL,LA JOLLA,CA 92037
[4] UNIV ALABAMA,DEPT MED PATHOL PEDIAT & MICROBIOL,DIV DEV & CLIN IMMUNOL,BIRMINGHAM,AL 35294
关键词
MB-1; B29; HS1; IGM; IGD; TYROSINE PHOSPHORYLATION;
D O I
10.1016/0165-2478(94)90208-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies of murine and human B lymphocytes have shown that crosslinking of surface IgM (sIgM) and sIgD stimulates tyrosine phosphorylation of a set of proteins involved in signal transduction. We investigated tyrosine phosphorylation of the sig-associated proteins MB-1 and B29, and p75(HS1) (HS1), and the association of HS1 with MB-1/B29 heterodimers in normal human B cells and a human B lymphoma cell line, B104. Using immunoprecipitation with anti-phosphotyrosine antibodies (Abs) followed by immunoblotting with anti-MB-1 Abs, anti-B29 Abs or anti-HS1 Abs, we demonstrated that MB-1, B29 and HS1 were tyrosine-phosphorylated after sIgM or sIgD crosslinking. Immunoprecipitation with anti-B29 Abs followed by anti-HS1 Abs immunoblotting revealed that HS1 was associated with MB-1/B29 heterodimers after sIgM or sIgD crosslinking. The results showed that HS1 may play an important role in signal transduction through sIgM and sIgD on human B cells.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 50 条
  • [41] Tyrosine phosphorylation of specific human bone marrow stromal cell proteins following contact with human B cells.
    Jarvis, LJ
    LeBien, TW
    BLOOD, 1995, 86 (10) : 2365 - 2365
  • [42] CROSS-LINKING SURFACE IG AND THE LOW AFFINITY IGE FC RECEPTOR INDUCES B-CELLS TO ENTER CELL-CYCLE
    WALDSCHMIDT, T
    TYGRETT, L
    FASEB JOURNAL, 1991, 5 (04): : A610 - A610
  • [43] CROSS-LINKING THE LEU-8 LYMPH-NODE HOMING RECEPTOR ON B-CELLS INHIBITS IMMUNOGLOBULIN-SYNTHESIS
    MURAKAWA, Y
    STROBER, W
    JAMES, SP
    IMMUNOLOGIC RESEARCH, 1991, 10 (3-4) : 441 - 446
  • [44] The tyrosine phosphatase 1B regulates linker for activation of T-cell phosphorylation and platelet aggregation upon FcγRIIa cross-linking
    Ragab, A
    Bodin, S
    Viala, C
    Chap, H
    Payrastre, B
    Ragab-Thomas, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) : 40923 - 40932
  • [45] PERTURBATION OF INSULIN-RECEPTOR INTERACTIONS BY INTRAMOLECULAR HORMONE CROSS-LINKING - ANALYSIS OF RELATIVE MOVEMENT AMONG RESIDUE-A1, RESIDUE-B1, AND RESIDUE-B29
    NAKAGAWA, SH
    TAGER, HS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (01) : 272 - 279
  • [46] Regulatory elements of the mb-1 gene encoding the Ig-alpha component of the human B-cell antigen receptor
    Leduc, I
    Cogne, M
    MOLECULAR IMMUNOLOGY, 1996, 33 (17-18) : 1277 - 1286
  • [47] Activation of Rac and tyrosine phosphorylation of cytokine receptors induced by cross-linking of integrin α4β1 and cell adhesion in hematopoietic cells
    Kanda, E
    Jin, ZH
    Mizuchi, D
    Arai, A
    Miura, O
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (04) : 934 - 940
  • [48] ACTIVATION AND SERINE PHOSPHORYLATION OF THE P56(LCK) PROTEIN-TYROSINE KINASE IN RESPONSE TO ANTIGEN RECEPTOR CROSS-LINKING IN B-LYMPHOCYTES
    GOLD, MR
    CHIU, R
    INGHAM, RJ
    SAXTON, TM
    VANOOSTVEEN, I
    WATTS, JD
    AFFOLTER, M
    AEBERSOLD, R
    JOURNAL OF IMMUNOLOGY, 1994, 153 (06): : 2369 - 2380
  • [49] Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells
    Vallat, Laurent D.
    Park, Yuhyun
    Li, Cheng
    Gribben, John G.
    BLOOD, 2007, 109 (09) : 3989 - 3997
  • [50] A MONOVALENT C(MU)4-SPECIFIC LIGAND ENHANCES THE ACTIVATION OF HUMAN B-CELLS BY MEMBRANE IGM CROSS-LINKING LIGANDS
    MONGINI, PKA
    BLESSINGER, CA
    CHIORAZZI, N
    RAJARAM, N
    RUDICH, SM
    INTERNATIONAL IMMUNOLOGY, 1995, 7 (02) : 317 - 330